DuoResp Spiromax

budesonide/formoterol fumarate dihydrate · Teva Pharma B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DuoResp Spiromax, covering 2024-07-24 to 2024-07-24. Get the full timeline:

Most recent: EMA Authorised: DuoResp Spiromax (Budesonide;formoterol fumarate dihydrate) — Teva Pharma B.V.